ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Synthesis of the C‑1ÀC-17 Fragment
of Amphidinolides C, C2, C3, and F
J. Stephen Clark,* Guang Yang, and Andrew P. Osnowski
WestCHEM, School of Chemistry, Joseph Black Building, University of Glasgow,
University Avenue, Glasgow G12 8QQ, United Kingdom
Received February 21, 2013
ABSTRACT
The C-1ÀC-17 fragment of amphidinolides C, C2, C3, and F has been constructed from a trans-2,5-disubstituted dihydrofuranone prepared by
diastereoselective rearrangement of a free or metal-bound oxonium ylide generated from a metal carbenoid. The dihydrofuranone was converted
into an aldehyde corresponding to the C-1ÀC-8 framework, and this was coupled to the C-9ÀC-17 unit by nucleophilic addition of a vinylic anion.
AmphidinolidesC, C2, C3, and Farestructurallyrelated
members of a large family of marine natural products
isolated from microalgae of amphidinium sp. (Figure 1).
Amphidinolide C possesses substantial anticancer activity
(IC50 values <0.01 μg mLÀ1 against certain cell lines).1
(1) (a) Kobayashi, J. J. Antibiot. 2008, 61, 271. (b) Kobayashi, J.;
Ishibashi, M. Chem. Rev. 1993, 93, 1753. (c) Kobayashi, J.; Tsuda, M.
Nat. Prod. Rep. 2004, 21, 77. (d) Kobayashi, J.; Shimbo, K.; Kubota, T.;
Tsuda, M. Pure Appl. Chem. 2003, 75, 337.
€
(2) (a) Kobayashi, J.; Ishibashi, M.; Walchli, M. R.; Nakamura, H.;
Hirata, Y.; Sasaki, T.; Ohizumi, Y. J. Am. Chem. Soc. 1988, 110, 490. (b)
Ishiyama, H.; Ishibashi, M.; Kobayashi, J. Chem. Pharm. Bull. 1996, 44,
1819. (c) Kubota, T.; Tsuda, M.; Kobayashi, J. Org. Lett. 2001, 3, 1363.
(d) Kubota, T.; Tsuda, M.; Kobayashi, J. Tetrahedron 2003, 59, 1613.
(3) Kubota, T.; Sakuma, Y.; Tsuda, M.; Kobayashi, J. Mar. Drugs
2004, 2, 83.
(4) Kubota, T.; Suzuki, A.; Yamada, M.; Baba, S.; Kobayashi, J.
Heterocycles 2010, 82, 333.
(5) Kobayashi, J.; Tsuda, M.; Ishibashi, M.; Shigemori, H.; Yamasu,
T.; Hirota, H.; Sasaki, T. J. Antibiot. 1991, 44, 1259.
(6) (a) Shotwell, J. B.; Roush, W. R. Org. Lett. 2004, 6, 3865. (b)
Mohapatra, D. K.; Rahaman, H.; Chorghade, M. S.; Gurjar, M. K.
Synlett 2007, 4, 567. (c) Bates, R. H.; Shotwell, J. B.; Roush, W. R. Org.
Lett. 2008, 10, 4343. (d) Armstrong, A.; Pyrkotis, C. Tetrahedron Lett.
2009, 50, 3325. (e) Mahapatra, S.; Carter, R. G. Org. Biomol. Chem.
2009, 7, 4582. (f) Paudyal, M. P.; Rath, N. P.; Spilling, C. D. Org. Lett.
Figure 1. Amphidinolides C, C2, C3, and F.
The unique structures and bioactivities of amphidinolides
C,2 C2,3 C3,4 and F5 have aroused significant interest in
their syntheses, and several groups have reported syntheses
of fragments of the compounds.6 Very recently, Carter and
Mahapatra completed a synthesis of amphidinolide F in
which a common intermediate was used to prepare both
tetrahydrofurans.7
ꢀ
ꢁ
2010, 12, 2954. (g) Ferrie, L.; Figadere, B. Org. Lett. 2010, 12, 4976.
(h) Roy, S.; Spilling, C. D. Org. Lett. 2010, 12, 5326. (i) Morra, N. A.;
Pagenkopf, B. L. Org. Lett. 2011, 13, 572.
(7) Mahapatra, S.; Carter, R. G. Angew. Chem., Int. Ed. 2012,
51, 7948.
r
10.1021/ol4004838
XXXX American Chemical Society